Xylopine Induces Oxidative Stress and Causes G2/M Phase Arrest, Triggering Caspase-Mediated Apoptosis by p53-Independent Pathway in HCT116 Cells

Xylopine is an aporphine alkaloid that has cytotoxic activity to Cancer cells. In this study, the underlying mechanism of xylopine cytotoxicity was assessed in human colon carcinoma HCT116 cells. Xylopine displayed potent cytotoxicity in different Cancer cell lines in monolayer cultures and in a 3D model of Cancer multicellular spheroids formed from HCT116 cells. Typical morphology of Apoptosis, cell cycle arrest in the G₂/M phase, increased internucleosomal DNA fragmentation, loss of the mitochondrial transmembrane potential, and increased phosphatidylserine externalization and Caspase-3 activation were observed in xylopine-treated HCT116 cells. Moreover, pretreatment with a Caspase-3 inhibitor (Z-DEVD-FMK), but not with a p53 inhibitor (cyclic pifithrin-α), reduced xylopine-induced Apoptosis, indicating induction of caspase-mediated Apoptosis by the p53-independent pathway. Treatment with xylopine also caused an increase in the production of reactive oxygen/nitrogen species (ROS/RNS), including hydrogen peroxide and nitric oxide, but not superoxide anion, and reduced glutathione levels were decreased in xylopine-treated HCT116 cells. Application of the antioxidant N-acetylcysteine reduced the ROS levels and xylopine-induced Apoptosis, indicating activation of ROS-mediated Apoptosis pathway. In conclusion, xylopine has potent cytotoxicity to different Cancer cell lines and is able to induce oxidative stress and G₂/M phase arrest, triggering caspase-mediated Apoptosis by the p53-independent pathway in HCT116 cells.